Oxford Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Oxford Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,390,405	Closed	-$5.56M	–	1711
2019 Q4	$5.56M	Buy	1,390,405 +1,349,391	+3,290%	+$6.34M	0.15%	145
2019 Q3	$201K	Buy	+41,014	New	+$229K	﹤0.01%	1575
2018 Q1	–	Sell	-107,546	Closed	-$2.18M	–	2021
2017 Q4	$2.18M	Buy	+107,546	New	+$2.11M	0.05%	527
2017 Q3	–	Sell	-145,899	Closed	-$2.16M	–	1794
2017 Q2	$2.16M	Buy	+145,899	New	+$2.43M	0.04%	573

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Oxford Asset Management's DPLO Position: Q1 2020 in Review

Oxford Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,390,405 shares — an estimated $5.56M sold.

Oxford Asset Management first reported a position in DPLO in Q2 2017 and held it in 4 quarters. The position peaked at $5.56M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Oxford Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 1,390,405 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $5.56M.
Oxford Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 4 quarters.
Oxford Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $5.56M in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.